{"url_path":"/sec/aim/8-k/2026-05-21/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 ** **Unregistered Sales of Equity Securities.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/946644/0001493152-26-024760-index.html","accession_number":"0001493152-26-024760","cik":"0000946644","ticker":"AIM","issuer_name":"AIM ImmunoTech Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/946644/0001493152-26-024760-index.html","primary_entity_key":"0000946644","primary_entity_name":"AIM ImmunoTech Inc."},"word_count":121,"has_tables":true,"body_markdown":"**Item 3.02** **Unregistered Sales of Equity Securities.**\n\n \n\nThe\ninformation set forth in Item 1.01 of this Current Report on Form 8-K with respect to the Common Warrants and the Common Warrant Shares\nis incorporated herein by reference.\n\n \n\nThe\nCommon Warrants and the Placement Agent Warrants will be issued in a private placement pursuant to the exemption from the registration\nrequirements of the Securities Act, provided by Section 4(a)(2) thereof as transactions not involving a public offering and/or Rule 506\npromulgated thereunder as sales to accredited investors. The Common Warrant Shares and the shares of Common Stock underlying the Placement\nAgent Warrants have not been registered under the Securities Act and will be issued, if at all, pursuant to the same exemption."}